Biological activity of AC3174, a peptide analog of exendin-4-Reference-Cited by-同舟云学术

Biological activity of AC3174, a peptide analog of exendin-4

Published:2007-06 Issue:1-3 Volume:141 Page:113-119
ISSN:0167-0115
Container-title:Regulatory Peptides
language:en
Short-container-title:Regulatory Peptides

Author:

Hargrove Diane M.,Kendall Eric S.,Reynolds James M.,Lwin Aung N.,Herich John P.,Smith Pamela A.,Gedulin Bronislava R.,Flanagan Shawn D.,Jodka Carolyn M.,Hoyt Julie A.,McCowen Kevin M.,Parkes David G.,Anderson Christen M.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Clinical Biochemistry,Endocrinology,Physiology,Biochemistry

Reference26 articles.

1. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas;Eng;J Biol Chem,1992

2. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells;Goke;J Biol Chem,1993

3. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor;Thorens;Diabetes,1993

4. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes;Buse;Diabetes Care,2004

5. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes mellitus;DeFronzo;Diabetes Care,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycosylation Improves the Proteolytic Stability of Exenatide;Bioconjugate Chemistry;2023-05-16

2. Developing a novel exenatide-based incretin mimic (αB-Ex): Expression, purification and structural-functional characterization;Biochimica et Biophysica Acta (BBA) - General Subjects;2022-07

3. Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP;Drug Design, Development and Therapy;2022-05

4. Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy;Molecular Metabolism;2021-01

5. Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist;Molecules;2020-05-28